Number 13

UICC – taking on mission impossible

Editorial 1 July 2006 0

For almost 75 years the International Union Against Cancer (UICC) has been the only international non-governmental organisation dedicated exclusively to the global control of cancer. But with many societies currently ‘going global’, including ASCO and [more]

... [ more ]

David Khayat: driving the French cancer plan

Cover Story 1 July 2006 0

A committed medical oncologist, David Khayat reluctantly dragged himself away from his patients in 2003 to oversee the implementation of the French cancer plan. This grand and sweeping venture exercises huge control over cancer services, [more]

... [ more ]

Are you feeling lucky?

Grandround 1 July 2006 0

Doctors use trial-based evidence and years of experience to assess risks of treatment and relapse. But patients make choices based on their own experiences and priorities. How can doctors best explore treatment options with patients? [more]

... [ more ]

RNA-bound: the future of antisense drugs

Drug Watch 1 July 2006 0

The use of nucleic acid therapies to block RNA function was first described in 1978. The latest generation of these compounds, LNA antagonists, is now overcoming the main obstacle to the success of its predecessors, [more]

... [ more ]

Has TNM been overtaken by science?

Senza categoria 1 July 2006 0

The biology of a cancer is a key factor determining prognosis and prediction of response. So should we still be characterising it by the size of the tumour and spread of the disease? In a [more]

... [ more ]

The Moscow smokebuster

Senza categoria 1 July 2006 0

There are smokers in Russia alive today thanks to David Zaridze and the lead he took in halving tar levels 20 years ago. He has a long history in cancer prevention, but believes the biggest [more]

... [ more ]

Does regular use of aspirin reduce the risk of colorectal cancer?

Impact Factor 1 July 2006 0

Use of at least two standard aspirin weekly, for 10 years or more, reduces colon cancer risk in women. Subject to certain caveats, aspirin should be considered for colon cancer prophylaxis. Download full article

... [ more ]

Factors predictive for response of follicular and mantle cell lymphoma to rituximab

Impact Factor 1 July 2006 0

A recent analysis of prognostic factors may help identify which follicular and mantle cell lymphoma patients should be excluded from trials of single-agent rituximab therapy. Download full article

... [ more ]

NEWSROUND

Senza categoria 1 July 2006 0

Selected press reports compiled by the ESO Cancer Media Centre Download full article

... [ more ]